Yuliya Kupriyanova
Overview
Explore the profile of Yuliya Kupriyanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kupriyanova Y, Yurchenko I, Bobrov P, Bartels F, Wierichs S, Jonuscheit M, et al.
BMJ Open Diabetes Res Care
. 2025 Feb;
13(1).
PMID: 39965871
Introduction: The study aimed to assess the effect of COVID-19 on hepatic lipid (HL) content, fibrosis risk, and adiposity in persons with type 2 diabetes. Research Design And Methods: Participants...
2.
Pesta D, Anadol-Schmitz E, Sarabhai T, Op den Kamp Y, Gancheva S, Trinks N, et al.
Sci Adv
. 2025 Jan;
11(1):eadr8849.
PMID: 39742483
The athlete's paradox states that intramyocellular triglyceride accumulation associates with insulin resistance in sedentary but not in endurance-trained humans. Underlying mechanisms and the role of muscle lipid distribution and composition...
3.
Zaharia O, Strassburger K, Knebel B, Binsch C, Kupriyanova Y, Moser C, et al.
Diabetes Metab Syndr
. 2024 Oct;
18(10):103137.
PMID: 39427597
Aims: We examined the association of the G allele in the single-nucleotide polymorphism (SNP) rs738409 in the third exon of patatin-like phospholipase domain-containing 3 gene (PNPLA3) gene, with chronic kidney...
4.
Schaefer E, Lang A, Kupriyanova Y, Bodis K, Weber K, Buyken A, et al.
Diabetes Obes Metab
. 2024 Jul;
26(10):4281-4292.
PMID: 39010284
Aim: To investigate the associations of the Dietary Approaches to Stop Hypertension (DASH) score with subcutaneous (SAT) and visceral (VAT) adipose tissue volume and hepatic lipid content (HLC) in people...
5.
Jonuscheit M, Wierichs S, Rothe M, Korzekwa B, Mevenkamp J, Bobrov P, et al.
NMR Biomed
. 2024 Feb;
37(8):e5120.
PMID: 38404058
Concentrations of the key metabolites of hepatic energy metabolism, adenosine triphosphate (ATP) and inorganic phosphate (P), can be altered in metabolic disorders such as diabetes mellitus. Phosphorus (P)-magnetic resonance spectroscopy...
6.
Schon M, Prystupa K, Mori T, Zaharia O, Bodis K, Bombrich M, et al.
Lancet Diabetes Endocrinol
. 2023 Dec;
12(2):119-131.
PMID: 38142707
Background: Heterogeneity in type 2 diabetes can be represented by a tree-like graph structure by use of reversed graph-embedded dimensionality reduction. We aimed to examine whether this approach can be...
7.
Zaharia O, Antoniou S, Bobrov P, Karusheva Y, Bodis K, Kupriyanova Y, et al.
Diabetes Care
. 2023 Oct;
46(12):2232-2239.
PMID: 37874983
Objective: Diabetes may feature impaired insulin kinetics, which could be aggravated by altered hepatic metabolism and glycemic control. Thus, we examined insulin clearance and its possible determinants in individuals with...
8.
Saatmann N, Schon M, Zaharia O, Huttasch M, Strassburger K, Trenkamp S, et al.
Liver Int
. 2023 Sep;
44(1):27-38.
PMID: 37697960
Background And Aims: Non-alcoholic fatty liver disease (NAFLD) has been linked to type 2 diabetes (T2D), but also to hypothyroidism. Nevertheless, the relationship between thyroid function and NAFLD in diabetes...
9.
Michelotti F, Kupriyanova Y, Mori T, Kustner T, Heilmann G, Bombrich M, et al.
J Magn Reson Imaging
. 2023 Aug;
59(4):1193-1203.
PMID: 37530755
Background: Water T of the liver has been shown to be promising in discriminating the progressive forms of fatty liver diseases, inflammation, and fibrosis, yet proper correction for iron and...
10.
Bodis K, Bombrich M, Schon M, Knebel B, Zaharia O, Bonhof G, et al.
Nutr Metab Cardiovasc Dis
. 2023 Jul;
33(9):1785-1796.
PMID: 37495452
Background And Aims: Increased hepatocellular lipid content (HCL) is linked to insulin resistance, risk of type 2 diabetes and related complications. Conversely, a single-nucleotide polymorphism (TM6SF2; rs58542926) in the transmembrane...